A potential target for experimental drugs that block PRMT5 - a naturally occurring enzyme some tumors rely more on for ...

Enzymes are vital to metabolism and drive countless biological processes in humans, plants, and industry. Yet, when ...

During a live event, Mark Yarchoan, MD, and participants reviewed adverse event management for 3 different combination ...

Massey Comprehensive Cancer Center is the first U.S. site to enroll patients in a global trial of first-in-class therapy for skin-related T-cell lymphoma -- a rare type of non-Hodgkin lymphoma that ...

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological ...

In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

New research suggests that COVID-19 can lead to protein build-up similar to that seen in Alzheimer's patients, not just in ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

MADRID and CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in ...